Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

VTGNNasdaq

Vistagen Therapeutics, Inc.

Alert me on VTGN

0

Insider buys, 6 months

0

Congress trades, 6 months

0

Signals, 6 months

Six months

After each filing

No purchase or sale on this ticker by a member of Congress or an insider yet.

Filings for VTGN

34 held · newest 534 held · newest 2

Loading the filings.

See all 34 filings for VTGN

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

16

Jun 30, 2026 Schedule 13G, amended

ORBIMED ADVISORS LLC: 0%, 0 shares

Jun 30, 2026 Schedule 13G, amended

Chen Yu: 6.7%, 2,960,404 shares

Jun 30, 2026 Schedule 13G, amended

Commodore Capital LP: 9.9%, 4,244,590 shares

Mar 31, 2026 Schedule 13G, amended

Chen Yu: 10%, 4,100,029 shares

Dec 31, 2025 Schedule 13G, amended

ORBIMED CAPITAL LLC: 4.2%, 1,639,700 shares

Dec 31, 2025 Schedule 13G, amended

Commodore Capital LP: 9.9%, 4,383,508 shares

Dec 31, 2025 Schedule 13G, amended

Great Point Partners, LLC: 5%, 2,055,834 shares

Dec 31, 2025 Schedule 13G, amended

JANUS HENDERSON GROUP PLC: 0%, 0 shares

Dec 31, 2025 Schedule 13G, amended

StemPoint Capital LP: 1.5%, 616,749 shares

Dec 31, 2025 Schedule 13G, amended

Nantahala Capital Management, LLC: 4.7%, 1,953,045 shares

Dec 31, 2025 Schedule 13G, amended

The Vanguard Group: 4.6%, 1,824,738 shares

Sep 30, 2025 Schedule 13G

ORBIMED CAPITAL LLC: 5.3%, 1,639,700 shares

Sep 30, 2025 Schedule 13G, amended

Nantahala Capital Management, LLC: 10%, 3,185,564 shares

Sep 30, 2025 Schedule 13G, amended

Great Point Partners, LLC: 6.3%, 2,055,834 shares

Sep 30, 2025 Schedule 13G, amended

The Vanguard Group: 5.5%, 1,687,735 shares

Aug 29, 2025 Schedule 13G

JANUS HENDERSON GROUP PLC: 13.6%, 4,165,767 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.